// Script to change toggle default state //G Smith second script to show/hide Leadership sections

Research Articles

NeOnc continues a rigorous path of research and development into its formulation to show efficacy and examine complementary areas of use where its products can be of benefit.

Study Shows NEO400 Has Therapeutic Effect On UV-Induced Skin Damage

Study Shows NEO400 Has Therapeutic Effect On UV-Induced Skin Damage

NEO100 Enhances Entry And Therapeutic Activity Of Chimeric Antigen Receptor T Cells

NEO100 Enhances Entry And Therapeutic Activity Of Chimeric Antigen Receptor T Cells

Transfemoral Injection of NEO100 Provides Potential for Delivery of Therapeutics to the Brain

Transfemoral Injection of NEO100 Provides Potential for Delivery of Therapeutics to the Brain

Postsurgical Biopsy Shows Viability of NEO100 Intranasal Delivery

Postsurgical Biopsy Shows Viability of NEO100 Intranasal Delivery

NEO-212 Shows Promise In Treating Acute Myeloid Leukemia

NEO-212 Shows Promise In Treating Acute Myeloid Leukemia

NEO100 Enhances Delivery Of Herceptin For Treatment Of Metastatic Breast Cancer In The Brain

NEO100 Enhances Delivery Of Herceptin For Treatment Of Metastatic Breast Cancer In The Brain

NEO100 Human Trial In Adult Patients With Recurrent Glioblastoma

NEO100 Human Trial In Adult Patients With Recurrent Glioblastoma

Understanding The Pharmacokinetic Properties Of NEO 212

Understanding The Pharmacokinetic Properties Of NEO 212

Study Supporting NEO100’s Ability To Deliver Through The BBB

Study Supporting NEO100’s Ability To Deliver Through The BBB

Improving Therapeutic Efficacy For Brain-Based Cancers Using NEO100

Improving Therapeutic Efficacy For Brain-Based Cancers Using NEO100

NEO 212 Enhances Temozolomide’s Ability To Increase Radiosensitivity And Cytotoxicity In Glioblastoma Tumors

NEO 212 Enhances Temozolomide’s Ability To Increase Radiosensitivity And Cytotoxicity In Glioblastoma Tumors

Intranasal Delivery Of BZM With NEO 100 Prolonged Survival Of Glioblastoma Tumors In Animals

Intranasal Delivery Of BZM With NEO 100 Prolonged Survival Of Glioblastoma Tumors In Animals

NEO214 Shown To Be A Mediator Of Cell Death In Patients With TMZ-Resistant GBM

NEO214 Shown To Be A Mediator Of Cell Death In Patients With TMZ-Resistant GBM

POH Shows Ability To Bypass The Blood Brain Barrier For Intranasal Delivery Of Therapeutics

POH Shows Ability To Bypass The Blood Brain Barrier For Intranasal Delivery Of Therapeutics

TMZ-POH Shows Positive Effect On Patients With Nasopharyngeal Carcinoma.

TMZ-POH Shows Positive Effect On Patients With Nasopharyngeal Carcinoma.

NEO212 Shows Ability To Help Block Pro-Angiogenic And Invasive Characteristics Of GBM

NEO212 Shows Ability To Help Block Pro-Angiogenic And Invasive Characteristics Of GBM

Further NEO 212 Studies Shows Ability To Slow GBM Cell Invasion at Sub-Cytotoxic Dose

Further NEO 212 Studies Shows Ability To Slow GBM Cell Invasion at Sub-Cytotoxic Dose

NEO100 Enables Noninvasive, Effective Delivery of Therapeutics

NEO100 Enables Noninvasive, Effective Delivery of Therapeutics

NEO214 Effectively Kills Multiple Myeloma Cells With An Order Of Magnitude Stronger Than Its Individual Components

NEO214 Effectively Kills Multiple Myeloma Cells With An Order Of Magnitude Stronger Than Its Individual Components

Initial Study Shows The Cytotoxic Effects Of Intranasal Delivered POH

Initial Study Shows The Cytotoxic Effects Of Intranasal Delivered POH